Texas (August 16, 2013) Wax Ink has issued a Negative Investment Interest opinion for Sigma-Aldrich Corporation (Nasdaq: SIAL) based on a recent baseline equity review which placed fair value between $56-$65.
The recent close of $84.40 is approximately 151% above the fair value buy target for the stock and approximately 22% above the fair value close target for the stock. The recent close is also 4% below analysts' twelve-month $81.00 median price target for the stock.
The recent close represents an 18% increase in the year over year price of the stock, while for the same period sales increased 5%, and earnings increased 8%.
The stock currently has a trailing twelve-month PE Ratio of 17, and a PEG Ratio of 2.0 basis estimated forward earnings growth of 8.50%.
In the past 52 weeks, share prices have moved between a high of $86.35 and a low of $68.22, placing equilibrium at $80.50.
Basis the recent close, the stock is trading 2% below the 52 week high, 19% above the 52 week low, and 5% above equilibrium. The three month average daily trading volume is approximately 608,000 shares.
Sigma-Aldrich Corporationa life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment worldwide.
The company's listed competitors include Bayer AG, Brenntag AG, and VWR Funding, Inc..
Financial information that may be contained herein, is based on the company's most recent annual SEC filing for year ending December 31, 2012. All prices are per share unless otherwise noted.
Wax Ink currently has no investment position in any company mentioned in this alert.
For use by Accredited Investors as defined under Title 17, CFR §230.500, Regulation D.
Copyright © 2013 Wax Ink
Wax Ink is a baseline equity research company not licensed or registered with any government agency
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.